Page last updated: 2024-10-20

porphobilinogen and Leukemia, Myeloid, Acute

porphobilinogen has been researched along with Leukemia, Myeloid, Acute in 2 studies

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Olcay, L1
Hazirolan, T1
Yildirmak, Y1
Erdemli, E1
Terzi, YK1
Arda, K1
Oztürkmen, S1
Akyay, A1
Kaymak-Cihan, M1
Biçakçi, Z1
Bal, C1
Wehmeier, A1
Fischer, JT1
Goerz, G1
Schneider, W1

Trials

1 trial available for porphobilinogen and Leukemia, Myeloid, Acute

ArticleYear
Biochemical, radiologic, ultrastructural, and genetic evaluation of iron overload in acute leukemia and iron-chelation therapy.
    Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:4

    Topics: Adolescent; Aminolevulinic Acid; Bone Marrow; Bone Marrow Cells; Child; Female; Ferritins; Hemochrom

2014

Other Studies

1 other study available for porphobilinogen and Leukemia, Myeloid, Acute

ArticleYear
Polychemotherapy of acute myelogenous leukemia in a patient with acute intermittent porphyria.
    Klinische Wochenschrift, 1987, Apr-01, Volume: 65, Issue:7

    Topics: Acute Disease; Adult; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Chemical

1987